Sign in
4

Changes in Ownership

PALISADE BIO, INC. Filed Acc 0001493152-26-006257

Options or other derivatives

  • Chief Medical Officer acquired 787,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Jones Mitchell Lawrence Chief Medical Officer 2026-02-09 Grant or award · Restricted Stock Units +787,000 787,000 D: show line 1 in the form
Loading xslF345X05/ownership.xml…